U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323329) titled 'Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization' on Dec. 17, 2025.
Brief Summary: The goal of this study is to evaluate the role of Somatropin and Dehydroepiandrosterone (DHEA) on ovarian reserve parameters and intracytoplasmic sperm injection (ICSI) outcome in poor ovarian responder.
The main question it aims to answer is:
Which intervention is more effective in increasing number and size of follicles? Participants will be followed 1 month before starting induction in growth hormone and 12 weeks for DHEA and through intracytoplasmic sperm injection (ICSI) cycle.
Study Start Date: Oct. 10, 2025
Study Type: I...